Zobrazeno 1 - 10
of 389
pro vyhledávání: '"Hérault, L."'
Autor:
Bilous M; Department of Oncology, Ludwig Institute for Cancer Research Lausanne, University of Lausanne, 1011, Lausanne, Switzerland.; Agora Cancer Research Centre, 1011, Lausanne, Switzerland.; Swiss Cancer Center Leman (SCCL), Lausanne, Switzerland.; Swiss Institute of Bioinformatics (SIB), 1015, Lausanne, Switzerland., Hérault L; Department of Oncology, Ludwig Institute for Cancer Research Lausanne, University of Lausanne, 1011, Lausanne, Switzerland.; Agora Cancer Research Centre, 1011, Lausanne, Switzerland.; Swiss Cancer Center Leman (SCCL), Lausanne, Switzerland.; Swiss Institute of Bioinformatics (SIB), 1015, Lausanne, Switzerland., Gabriel AA; Department of Oncology, Ludwig Institute for Cancer Research Lausanne, University of Lausanne, 1011, Lausanne, Switzerland.; Agora Cancer Research Centre, 1011, Lausanne, Switzerland.; Swiss Cancer Center Leman (SCCL), Lausanne, Switzerland.; Swiss Institute of Bioinformatics (SIB), 1015, Lausanne, Switzerland., Teleman M; Department of Oncology, Ludwig Institute for Cancer Research Lausanne, University of Lausanne, 1011, Lausanne, Switzerland.; Agora Cancer Research Centre, 1011, Lausanne, Switzerland.; Swiss Cancer Center Leman (SCCL), Lausanne, Switzerland.; Swiss Institute of Bioinformatics (SIB), 1015, Lausanne, Switzerland., Gfeller D; Department of Oncology, Ludwig Institute for Cancer Research Lausanne, University of Lausanne, 1011, Lausanne, Switzerland. david.gfeller@unil.ch.; Agora Cancer Research Centre, 1011, Lausanne, Switzerland. david.gfeller@unil.ch.; Swiss Cancer Center Leman (SCCL), Lausanne, Switzerland. david.gfeller@unil.ch.; Swiss Institute of Bioinformatics (SIB), 1015, Lausanne, Switzerland. david.gfeller@unil.ch.
Publikováno v:
Molecular systems biology [Mol Syst Biol] 2024 Jul; Vol. 20 (7), pp. 744-766. Date of Electronic Publication: 2024 May 29.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Poplineau, M., Platet, N., Mazuel, A., Hérault, L., Koide, S., Kuribayashi, W., Carbuccia, N., N’guyen, L., Vernerey, J., Oshima, M., Birnbaum, D., Iwama, A., Duprez, Estelle
Cancer relapse is caused by a subset of malignant cells that are resistant to treatment. To characterize resistant cells and their vulnerabilities, we studied the retinoic acid (RA)-resistant PLZF-RARA acute promyelocytic leukemia (APL) using single-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::532d2770e6ac1ebd83ea602da23efd1d
https://hal.science/hal-03622501
https://hal.science/hal-03622501
Autor:
Poplineau M; Epigenetic Control of Normal and Malignant Hematopoiesis, CRCM, Aix Marseille University, CNRS UMR7258, INSERM U1068, Institut Paoli-Calmettes, Marseille, France.; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.; Equipe Labellisée Ligue Nationale Contre le Cancer., Platet N; Epigenetic Control of Normal and Malignant Hematopoiesis, CRCM, Aix Marseille University, CNRS UMR7258, INSERM U1068, Institut Paoli-Calmettes, Marseille, France.; Equipe Labellisée Ligue Nationale Contre le Cancer., Mazuel A; Epigenetic Control of Normal and Malignant Hematopoiesis, CRCM, Aix Marseille University, CNRS UMR7258, INSERM U1068, Institut Paoli-Calmettes, Marseille, France.; Equipe Labellisée Ligue Nationale Contre le Cancer., Hérault L; Epigenetic Control of Normal and Malignant Hematopoiesis, CRCM, Aix Marseille University, CNRS UMR7258, INSERM U1068, Institut Paoli-Calmettes, Marseille, France.; Equipe Labellisée Ligue Nationale Contre le Cancer.; MABioS, I2M, Aix Marseille University,CNRS UMR7373, Marseille, France., N'Guyen L; Epigenetic Control of Normal and Malignant Hematopoiesis, CRCM, Aix Marseille University, CNRS UMR7258, INSERM U1068, Institut Paoli-Calmettes, Marseille, France.; Equipe Labellisée Ligue Nationale Contre le Cancer., Koide S; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Nakajima-Takagi Y; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Kuribayashi W; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Carbuccia N; Predictive Oncology Laboratory, CRCM, Aix Marseille University, CNRS UMR7258, INSERM 1068, Institut Paoli-Calmettes, Marseille, France., Haboub L; Epigenetic Control of Normal and Malignant Hematopoiesis, CRCM, Aix Marseille University, CNRS UMR7258, INSERM U1068, Institut Paoli-Calmettes, Marseille, France.; Equipe Labellisée Ligue Nationale Contre le Cancer., Vernerey J; Epigenetic Control of Normal and Malignant Hematopoiesis, CRCM, Aix Marseille University, CNRS UMR7258, INSERM U1068, Institut Paoli-Calmettes, Marseille, France., Oshima M; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Birnbaum D; Predictive Oncology Laboratory, CRCM, Aix Marseille University, CNRS UMR7258, INSERM 1068, Institut Paoli-Calmettes, Marseille, France., Iwama A; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Duprez E; Epigenetic Control of Normal and Malignant Hematopoiesis, CRCM, Aix Marseille University, CNRS UMR7258, INSERM U1068, Institut Paoli-Calmettes, Marseille, France.; Equipe Labellisée Ligue Nationale Contre le Cancer.
Publikováno v:
Blood [Blood] 2022 Dec 01; Vol. 140 (22), pp. 2358-2370.
Autor:
Hérault L; Aix Marseille Université, CNRS, Marseille I2M, France.; Epigenetic Factors in Normal and Malignant Hematopoiesis Team, Aix Marseille Université, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France., Poplineau M; Epigenetic Factors in Normal and Malignant Hematopoiesis Team, Aix Marseille Université, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France., Duprez E; Epigenetic Factors in Normal and Malignant Hematopoiesis Team, Aix Marseille Université, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France., Remy É; Aix Marseille Université, CNRS, Marseille I2M, France.
Publikováno v:
Computational and structural biotechnology journal [Comput Struct Biotechnol J] 2022 Nov 02; Vol. 21, pp. 21-33. Date of Electronic Publication: 2022 Nov 02 (Print Publication: 2023).
Autor:
Hérault L; I2M, CNRS, Aix Marseille University, 13009 Marseille, France.; Epigenetic Factors in Normal and Malignant Hematopoiesis Lab., CRCM, CNRS, INSERM, Institut Paoli Calmettes, Aix Marseille University, 13009 Marseille, France., Poplineau M; Epigenetic Factors in Normal and Malignant Hematopoiesis Lab., CRCM, CNRS, INSERM, Institut Paoli Calmettes, Aix Marseille University, 13009 Marseille, France.; Equipe Labellisée Ligue Nationale Contre le Cancer, 75013 Paris, France., Remy E; I2M, CNRS, Aix Marseille University, 13009 Marseille, France., Duprez E; Epigenetic Factors in Normal and Malignant Hematopoiesis Lab., CRCM, CNRS, INSERM, Institut Paoli Calmettes, Aix Marseille University, 13009 Marseille, France.; Equipe Labellisée Ligue Nationale Contre le Cancer, 75013 Paris, France.
Publikováno v:
Cells [Cells] 2022 Oct 04; Vol. 11 (19). Date of Electronic Publication: 2022 Oct 04.
Autor:
Hérault L; Epigenetic Factors in Normal and Malignant Hematopoiesis Team, Aix Marseille Université, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France.; Aix Marseille Université, CNRS, Centrale Marseille, I2M, Marseille, France., Poplineau M; Epigenetic Factors in Normal and Malignant Hematopoiesis Team, Aix Marseille Université, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France., Mazuel A; Epigenetic Factors in Normal and Malignant Hematopoiesis Team, Aix Marseille Université, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France., Platet N; Epigenetic Factors in Normal and Malignant Hematopoiesis Team, Aix Marseille Université, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France., Remy É; Aix Marseille Université, CNRS, Centrale Marseille, I2M, Marseille, France., Duprez E; Epigenetic Factors in Normal and Malignant Hematopoiesis Team, Aix Marseille Université, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France. estelle.duprez@inserm.fr.
Publikováno v:
BMC biology [BMC Biol] 2021 Apr 16; Vol. 19 (1), pp. 80. Date of Electronic Publication: 2021 Apr 16.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hui, Harvard Wai Hann1 (AUTHOR), Kong, Weijia1,2 (AUTHOR), Goh, Wilson Wen Bin1,2,3,4,5 (AUTHOR) wilsongoh@ntu.edu.sg
Publikováno v:
Briefings in Bioinformatics. Nov2024, Vol. 25 Issue 6, p1-15. 15p.
Autor:
Conde-Lopez, Cristina1 (AUTHOR) cristina.condelopez@dkfz-heidelberg.de, Marripati, Divyasree2,3 (AUTHOR) divyasree@bgu.ac.il, Elkabets, Moshe2,3 (AUTHOR) moshee@bgu.ac.il, Hess, Jochen1,4 (AUTHOR) ina.kurth@dkfz-heidelberg.de, Kurth, Ina1 (AUTHOR)
Publikováno v:
Cancers. Oct2024, Vol. 16 Issue 19, p3265. 19p.